Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines i... by Patricia Izurieta, Dorota Borys

Get full text

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines... by Patricia Izurieta, Mohammad AbdelGhany, Dorota Borys

Get full text

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial. by Hanna Rinta-Kokko, Arto A Palmu, Esa Ruokokoski, Heta Nieminen, Marta Moreira, Lode Schuerman, Dorota Borys, Jukka Jokinen

Get full text

Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a... by Laura L Hammitt, John Ojal, Mahfudh Bashraheil, Susan C Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt, J Anthony G Scott

Get full text

Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9... by Qianhui Wu, Mengcen Qian, Sarah Welby, Adrienne Guignard, Dominique Rosillon, Kusuma Gopala, Yuan Xu, Keruo Liu, Yunkun He, Ning Jiang, Qin Tan, Jiamin Xie, Taoying Zhu, Qizhang Wang, Yingzi Pan, Ruikun Zeng, Jie Yang, Xiaoqian Zhao, Man Zhou, Adoración Navarro-Torné, Hongjie Yu, Dorota Borys

Get full text